Unilever 2025 Results: Premium Beauty, Wellbeing and Personal Care Drive Growth as Brand Investment Rises

Key Highlights:
Introduction
How Unilever reconfigured priorities—and why it matters
Beauty & Wellbeing: where premium innovation paid off
Personal Care: price-led growth with pockets of volume acceleration
Regional dynamics: Asia Pacific and Africa underpinned Q4 momentum
Why pricing and volume diverged across categories
Operating margins: deliberate compression for long‑term gain
Wellbeing: a discrete growth engine
Portfolio rationalisation: short‑term pain, long‑term focus
Digital commerce and premium: a structural accelerator
Competitive and retailer implications
Risks and headwinds to watch
What investors and managers should watch next
Strategic recommendations for Unilever and peers
Broader market implications: premiumisation and the future of CPG growth
Outlook for 2026 and what to expect
FAQ

Key Highlights:

Beauty & Wellbeing and Personal Care led Unilever’s 2025 topline, driven by premium, science‑led innovation across Dove, Vaseline, Hourglass and K18; Wellbeing brands (Nutrafol, Liquid I.V., OLLY) delivered double‑digit expansion.
Volume and price moves differed by category: Beauty saw balanced volume and price gains, Personal Care growth was more price‑led as commodity‑driven increases outweighed modest volume growth.
Operating profits fell as the company stepped up investment behind Power Brands and premium categories; regional momentum in Asia Pacific and Africa supported a strong fourth quarter.

Introduction

Unilever’s 2025 results reveal a company sharpening its commercial focus around beauty, wellbeing and premium personal care. The numbers show growth where Unilever has concentrated resources—science‑led innovations, targeted brand investment, and digital channel expansion—and strain where it has rationalised portfolios or navigated commodity price moves.

Beauty & Wellbeing and Personal Care together represent just over half of group turnover, and they registered solid underlying sales gains in 2025. Those gains, however, came with trade‑offs: operating margins slipped as Unilever accelerated marketing and product investment behind its Power Brands and premium segments. The results offer a timely case study in how a large consumer goods group repositions for higher‑margin categories while managing the short‑term earnings impact of that strategy.

This article unpacks the 2025 performance line by line. It assesses what drove growth, where pressure remains, how regional dynamics played out, and what those outcomes imply for Unilever’s strategy and competitors. Real‑world examples from within Unilever’s portfolio and the wider consumer goods industry illustrate how premiumisation, science‑led claims, and digital commerce are reshaping growth opportunities and margin management.

How Unilever reconfigured priorities—and why it matters

Fernando Fernandez, Unilever’s CEO, framed 2025 as an acceleration of the company’s strategic reshape: build a brand portfolio with more Beauty, Wellbeing and Personal Care, prioritise premium segments and digital commerce, and anchor growth in the US and India. That statement is more than corporate rhetoric. It reflects a deliberate reallocation of capital and management focus.

Why target these categories? Beauty and wellbeing typically deliver higher gross margins than basic household staples. They allow more differentiation, permit premium pricing, and respond to shifting consumer preferences—consumers increasingly seek functional benefits (scientifically validated claims, targeted formulations) and experiential qualities (sensory appeal, luxe packaging). Unilever’s move mirrors broader industry trends. Estée Lauder has long prioritised prestige beauty for margin expansion; Procter & Gamble has invested in premium hair and skin offerings that command higher price points. For Unilever, accelerating investment into premium brands is an attempt to capture that same value uplift across a much larger, more diverse portfolio.

The tactical elements of Unilever’s repositioning are visible in the 2025 accounts. The company boosted brand investment behind “Power Brands”—its global flagships such as Dove and Vaseline—while also backing faster‑growing, science‑led and premium acquisitions and innovations like K18 and Hourglass. Those shifts required increased marketing spend, product development investment and support for digital commerce infrastructure, all of which reduce near‑term operating profit but aim to compound brand equity over time.

Beauty & Wellbeing: where premium innovation paid off

Beauty & Wellbeing, accounting for 25% of group turnover, delivered underlying sales growth of 4.3% in 2025. That split into 2.2% volume growth and 2.1% price. Several clear patterns explain this performance.

Science‑led product innovation drove the strongest gains. Brands that leaned into clinically substantiated claims or novel technological propositions—K18 with its peptide‑based hair repair, Hourglass in prestige cosmetics, and Dove’s fibre‑repair hair range—posted the most meaningful uplifts. Vaseline continued an unusually strong run, delivering double‑digit growth for the third consecutive year. Core skin care supported mid‑single‑digit expansion through both volume and price.

The Wellbeing subcategory—nutraceuticals, supplements, and functional consumables—stood out. Nutrafol and Liquid I.V. delivered double‑digit growth; OLLY expanded at a high single‑digit rate, helped by premium gummy formats. This mirrors a broader consumer shift: demand for products that claim measurable health outcomes and convenience has accelerated, and CPG players who combine credible science with compelling formats have reaped the benefits. Nutrafol’s focus on clinical research and hair health protocols provides an example of how efficacy claims can convert into higher purchase frequency and premium pricing.

Hair care presented a mixed picture. Dove’s haircare business expanded strongly—double‑digit growth driven by balanced volume and price—thanks to its new fibre‑repair technology. That launch resembles large‑scale premiumisation efforts in the category, where established mass‑market brands migrate up the value chain through advanced formulations or salon‑grade claims. Conversely, Unilever’s portfolio rationalisation and softer performance in some emerging markets weighed on brands like Sunsilk and Clear, producing low single‑digit growth for Hair Care overall.

Prestige Beauty grew at a low single‑digit pace, primarily driven by pricing. While Hourglass and K18 recorded double‑digit growth, other prestige names such as Dermalogica and Paula’s Choice initially declined before returning to growth in the second half. This pattern is consistent with a premium category that is resilient but uneven—top‑performing niche brands with strong cultural resonance or unique science can grow quickly, while legacy specialty brands undergo cycles of renewal as they invest to reclaim growth.

Operating profit for Beauty & Wellbeing fell to €2.5bn, down 3.2% year‑on‑year. That decline reflects the costs of investment—marketing, product development, trade‑funding to support new launches and digital distribution—allocated to build market share in higher‑margin segments.

Real‑world comparison: Estée Lauder’s sustained prioritisation of prestige brands has produced similar trade‑offs historically—heavy investment behind innovation and distribution can depress current margins before profitability scales. Unilever appears to be following the same playbook at a much broader scope.

Personal Care: price-led growth with pockets of volume acceleration

Personal Care, representing 26% of Unilever’s turnover, achieved underlying sales growth of 4.7% in 2025. That comprised 1.1% from volume and 3.6% from price. The growth drivers and constraint mirror the category’s structure: commodity‑sensitive inputs (soaps, detergents, alcohols) enable price moves, while premium innovations provide the levers for incremental volume.

Commodity‑driven price increases lifted Personal Care’s top line. Unilever passed some input cost inflation through to consumers, which is common in CPG—raw material inflation for surfactants, packaging and fragrances typically underpins such decisions. At the same time, product premiumisation buoyed volumes in specific segments. Dove again was a standout, growing at a high single‑digit rate overall and leading deodorant and haircare gains.

Deodorants grew low single‑digit across the category, with Dove achieving double‑digit expansion driven by its Whole Body Deodorants. That subcategory shows how brand extensions—taking a trusted brand into adjacent formats—can unlock new revenue pools. Skin Cleansing expanded mid‑single‑digit, helped by pricing and premiumisation; Lifebuoy’s volumes were flat because consumers reacted to commodity‑led price rises. Oral Care grew mid‑single digit, supported by premium innovations in Closeup and Pepsodent—whitening and natural ingredient ranges that command higher price points.

Latin America was a drag on volumes for Personal Care, reflecting a slower consumer spend environment where price increases can suppress frequency. Developed market volume strength partially offset this regional weakness. Fourth‑quarter growth accelerated to 5.1%, with positive volume and an uptick in pricing.

Underlying operating profit for Personal Care was €3bn, down 1.4% from the prior year—again signalling the short‑term cost of investing behind product innovation and go‑to‑market activity.

Industry context: Procter & Gamble has deployed similar strategies across categories—using premium product tiers and format innovation to defend unit volumes as commodity inflation pressures core SKUs. Unilever’s experience suggests premium innovation works to sustain volumes in developed markets but is less potent where consumers are price sensitive.

Regional dynamics: Asia Pacific and Africa underpinned Q4 momentum

Unilever’s fourth‑quarter momentum was supported by improved performance in Asia Pacific and Africa. Those regions offered a combination of volume recovery and favourable price realisation, contributing to Q4 Beauty & Wellbeing growth of 4.7% (2.8% volume).

Asia Pacific and Africa are crucial for Unilever’s growth calculus for several reasons. They host large addressable populations, rising middle classes in markets such as India and parts of Southeast Asia, and opportunities for premiumisation where beauty and personal care penetration is still expanding. Many global players, including L’Oréal and P&G, have reported that growth in these regions tends to outpace mature markets when product innovation meets local consumer needs.

Unilever’s emphasis on India and the US as anchor markets reflects a dual strategy: capture high‑value premium consumers in the US and tap scale and premiumisation opportunities in India. India, specifically, offers unique growth physics—penetration gaps in premium formulations, rapid e‑commerce adoption, and a rising appetite for science‑led products tailored to local hair, skin and climate conditions.

Africa’s contribution to Q4 momentum is notable because it demonstrates the company’s ability to leverage price architecture and smaller pack formats to sustain volume in price‑sensitive markets. Single‑use sachets and smaller SKUs have historically been effective at maintaining access to consumers in lower‑income cohorts without abandoning margin dynamics.

What the regional data indicates practically: Unilever’s global playbook must be adapted locally. A K‑beauty style innovation may command premium pricing in parts of Asia and the US but must be reformulated, priced and distributed differently in Latin America or parts of Africa to secure scale.

Why pricing and volume diverged across categories

The 2025 results show a clear tension between price and volume. Beauty & Wellbeing’s growth was roughly evenly split between price and volume, while Personal Care’s growth skewed heavily to price.

Several forces explain this divergence:

Input cost dynamics. Categories with commodity‑heavy inputs or simpler formulations accepted price moves more readily. Personal Care’s pricing reflected commodity inflation that suppliers passed through.
Elasticity and premiumisation. Beauty categories with differentiated, science‑led innovations encountered lower price elasticity—the product benefits justified price increases and encouraged purchase frequency. Consumers were willing to trade up to premium variants, supporting volume as well as price.
Portfolio moves. Unilever’s rationalisation trimmed lower‑margin SKUs in Hair Care, which can lower overall volume while improving the quality of the portfolio.
Regional consumption patterns. Developed markets, with stronger wage dynamics and higher digital penetration, yielded volume gains for premium product launches. Latin America and other price‑sensitive regions experienced suppressed volume as price increases hit household budgets.

From a margin management perspective, price increases offer an immediate remedy to input cost pressure, but sustained margin improvement depends on volume retention and premium mix. If price hikes outpace perceived benefit, volumes will decline and erode long‑term brand equity.

A concrete example: Dove’s fibre‑repair hair range illustrates how product innovation can offset price increases—consumers accepted the price because they perceived a differentiated, clinically‑credible benefit. Lifebuoy, a function‑focused soap brand, faced volume pressure because incremental price increases offered less perceived value in fast‑moving, low‑consideration purchases.

Operating margins: deliberate compression for long‑term gain

Both Beauty & Wellbeing and Personal Care reported declines in underlying operating profit—€2.5bn (down 3.2%) and €3bn (down 1.4%), respectively. These reductions reflect higher investment behind Power Brands, premium categories and digital commerce.

Investing behind high‑potential brands often requires a period of negative margin impact. Marketing spend to launch premium ranges, support retail activation and expand DTC capabilities suppresses short‑term profitability. Product development costs are also significant for science‑led claims: clinical trials, laboratory research, and regulatory compliance carry a price tag that mass‑market commodity SKUs do not.

Unilever’s strategic choice is to prioritise sustainable brand equity and premium positioning over immediate margin protection. Historically, this approach works if investments convert into share gains and higher price elasticity. The company’s bet is that stronger brand desirability and improved format mix will deliver superior returns in subsequent periods.

Investors must observe conversion metrics: market share movement, repeat purchase rates for new premium SKUs, digital commerce revenue growth and gross margin expansion once the initial base of marketing investment stabilises. If those indicators lag, margin compression can signal impaired ROI.

Comparative note: When consumer goods companies such as Reckitt or P&G launched large premium lines, they accepted near‑term margin pressure to establish distribution and brand momentum; returns materialised over multiple quarters as scaling and mix shift occurred.

Wellbeing: a discrete growth engine

Unilever’s Wellbeing segment—nutraceuticals, hydration powders, vitamins and functional formats—stood out for double‑digit growth. Nutrafol, Liquid I.V., and OLLY emerged as the fastest drivers within this category. Their success highlights broader structural shifts:

Consumers increasingly view personal care and health as adjacent categories. Hair supplements (Nutrafol) can be as much about medical outcomes as aesthetic enhancement, and hydration mixes (Liquid I.V.) occupy the convenience health space.
DTC heritage and digital marketing. Liquid I.V. and OLLY grew heavily through omnichannel strategies that began in direct‑to‑consumer models and scaled into retail. These brands leveraged social proof, influencer channels, and subscription models.
Premium formats increase spend per transaction. Gummies, solubles and clinically‑validated supplements command higher unit prices than basic vitamins or over‑the‑counter commodities.

The implication for Unilever: Wellbeing offers superior growth potential and higher average order values. Capturing this requires science credibility, robust e‑commerce infrastructure, and careful route‑to‑market planning so that premium prices are accepted across different consumer segments and regions.

Real‑world mirror: Nestlé and Danone have both pursued nutrition and wellness strategies to diversify beyond commodity beverages and dairy. For Unilever, Wellbeing is a similar diversification into a higher‑growth, higher‑margin category.

Portfolio rationalisation: short‑term pain, long‑term focus

Unilever’s rationalisation of lower‑performing SKUs impacted category growth—Sunsilk and Clear experienced weaker performance as a result. Portfolio pruning is a classic tool for refocusing resources on higher growth and margin SKUs, but it can depress near‑term sales volumes.

Rationalisation serves multiple strategic aims:

Simplify supply chains and reduce complexity costs.
Reallocate marketing budgets to Power Brands with higher ROI.
Eliminate overlapping SKUs that cannibalise premium launches.

However, risks exist. Pruning must be accompanied by strong replacement activity—new launches, targeted pack sizes or pricing tiers—to avoid losing shelf presence and share to competitors. The challenge is magnified in emerging markets where brand loyalty can be fragile and distribution networks more complex.

A practical playbook includes: customer segmentation to identify which SKUs to retain for penetration versus margin, targeted promotional plans to transition consumers to new SKUs, and retailer negotiation to maintain shelf space for the reweighted portfolio.

Digital commerce and premium: a structural accelerator

Unilever explicitly prioritised digital commerce as part of its growth strategy. That prioritisation has material consequences:

Higher gross margins through DTC or first‑party channels because trade discounts are smaller and retailers’ cut is lower.
Direct consumer data for faster product iteration, personalised marketing and subscription models—an advantage in Wellbeing where repeat purchase is common.
Faster A/B testing of premium claims and pack architecture.

Brands such as Glossier and Harry’s demonstrated how direct engagement with consumers accelerates premium brand building. Liquid I.V. scaled through precise influencer strategies and native e‑commerce habits, then expanded into retail. Unilever intends to replicate that trajectory at scale across its Power Brands while leveraging retailer partnerships for wider distribution.

Digital commerce, however, requires incremental investment—platforms, logistics, customer service—and creates margin drag until scale is achieved. The 2025 operating profit declines partly reflect those upfront digital investments.

Competitive and retailer implications

Unilever’s premium pivot exerts pressure across the category:

Competitors will respond with sharpened R&D and marketing. P&G, L’Oréal, and specialty prestige houses are likely to accelerate their own science‑led launches and retailer promotions to defend share.
Retailers must balance shelf space between legacy mass brands and premium SKUs. Successful premiumisation requires retailers to curate assortments that facilitate discovery—endcaps for prestige launches, enhanced sampling programs, and digital in‑store integration.
Private label players may find opportunities where price sensitivity is high and premium conversion is lower. Retailers with strong own‑brand capabilities can capitalise on any downturn in demand caused by price increases.

For supermarket and pharmacy chains, the emergence of higher‑margin premium SKUs offers margin upside but increases complexity in inventory and promotions. The winners will be retailers that align their loyalty and digital platforms to support premium product discovery and repeat purchases.

Risks and headwinds to watch

Unilever’s 2025 performance demonstrates success in premium positioning but exposes several risks:

Macroeconomic sensitivity. If global consumer confidence weakens further, premium categories may experience backsliding as households prioritise essentials.
Pricing elasticity. Price increases supported by commodities can undermine volumes in price‑sensitive markets. Latin America’s volume weakness exemplifies this risk.
Execution across markets. Premium innovations must be adapted for local tastes and regulatory frameworks. A single global formula rarely fits all.
ROI on increased investment. Higher marketing and R&D spend must translate into sustained share gains. Failure to do so would pressure margins without strategic benefit.
Competitive responses. Rivals may accelerate promotions or launch competitive science‑led claims that blunt Unilever’s differentiation.

These risks do not negate the strategy but underscore the need for disciplined execution: sharp targeting of investment, rigorous measurement of new product performance, and the ability to scale digital commerce profitably.

What investors and managers should watch next

Investors and Unilever’s management will monitor several signals to assess whether the 2025 investments are delivering expected returns:

Market share movement in premium subsegments, particularly Beauty & Wellbeing and personal care premium tiers.
Repeat purchase and retention metrics for new premium launches and Wellbeing products.
Gross margin progression once initial launch and digital investments normalize.
Digital commerce revenue growth as a percentage of total sales and its margin profile.
Regional recovery or deterioration—India and the US should continue to be bellwethers for the strategy’s success.
Cost trajectory for commodities and packaging, and management’s ability to pass through or absorb these changes.

If premiumization sustains higher margins and digital commerce scales, Unilever’s short‑term margin compression will be viewed as a strategic investment, similar to prior cycles at other major consumer goods companies.

Strategic recommendations for Unilever and peers

Based on the 2025 results, the following course elements make sense for Unilever and any large CPG company pursuing similar objectives:

Continue targeted investment behind Power Brands but set clear, quantifiable KPIs for conversion to market share and repeat purchases.
Accelerate e‑commerce capabilities while optimising for profitability—balance customer acquisition with retention mechanics such as subscriptions and personalised promotions.
Localise premium innovations for emerging markets: adjust price architecture, pack sizes (e.g., sachets or smaller SKUs) and communication to match local purchasing power and cultural preferences.
Maintain a fast innovation pipeline with strong clinical validation where claims require credibility—partner with independent labs for third‑party validation to shorten consumer persuasion cycles.
Tighten SKU rationalisation with retailer collaboration to preserve shelf presence and allow smoother consumer migration from discontinued SKUs to premium alternatives.
Monitor input cost cycles and use hedging or long‑term supplier contracts where feasible to stabilise pricing decisions.

These actions aim to balance the dual goals of accelerating premium growth and restoring operating leverage.

Broader market implications: premiumisation and the future of CPG growth

Unilever’s results exemplify an industry theme: growth increasingly comes from differentiated, premium offerings rather than mass commodity SKUs. Two forces are central: consumers’ willingness to pay for demonstrable benefits, and the distribution advantages of digital commerce.

Premiumisation, however, is not purely about raising prices. It requires investment in product efficacy, storytelling, packaging and omnichannel access. Brands that succeed do so by convincing shoppers that the incremental spend delivers superior utility or experience. That dynamic elevates the importance of R&D and credible clinical evidence in categories from hair and skin to ingestible wellness products.

The rise of Wellbeing as a growth engine also signals a longer cycle of convergence between health, beauty and nutrition. Companies that can credibly span those adjacent categories with science‑backed formats will have multiple routes to grow average basket value and frequency.

Finally, the interplay between regional strategy and global brand building will determine winners. A premium product that succeeds in the US or parts of Asia will not automatically scale globally. Executional agility at local levels—pack size, pricing, distribution partnerships—is as important as corporate strategy.

Outlook for 2026 and what to expect

Fernando Fernandez signalled confidence for 2026 despite a backdrop of slowing markets. The key to sustaining that optimism will be execution:

Convert new premium launches into recurring revenue streams.
Scale digital channels efficiently so that higher gross margins from DTC offset the upfront investment.
Manage price elasticity carefully in regions under consumer stress, avoiding wide volume erosion.
Continue portfolio rationalisation but pair it with clear migration paths for consumers and retailers.

If Unilever successfully turns its 2025 investment budget into sustained share gain and improves operating leverage, the strategy will validate the short‑term margin sacrifice. If not, the company will face pressure from investors to clarify ROI timelines and potentially temper growth ambitions.

FAQ

Q: Which Unilever categories drove growth in 2025? A: Beauty & Wellbeing and Personal Care were the primary growth drivers. Within Beauty & Wellbeing, vaseline and Dove performance, along with Wellbeing brands like Nutrafol and Liquid I.V., delivered strong expansion. Personal Care growth was supported by premium innovations (notably Dove) even as price increases contributed significantly.

Q: Why did operating profit decline even though sales grew? A: Unilever increased investment behind Power Brands and premium categories—marketing, R&D for science‑led products, and digital commerce capabilities. These investments depressed operating profit in the short term while aiming to drive higher margin growth in future periods.

Q: How did pricing and volume contribute to growth? A: Beauty & Wellbeing showed a roughly even split between price and volume. Personal Care growth was more price‑led, with commodity‑driven input costs prompting price increases; volume gains in developed markets were offset by declines in regions like Latin America.

Q: Which regions showed the strongest recovery in Q4? A: Asia Pacific and Africa supported fourth‑quarter momentum, delivering improved volume and positive pricing dynamics that helped raise Q4 growth.

Q: Are Wellbeing categories sustainable growth engines for Unilever? A: Wellbeing brands demonstrated strong performance in 2025, driven by premium formats, credible science and e‑commerce strategies. Sustainability depends on Unilever’s ability to scale DTC profitably, maintain efficacy claims, and expand distribution without overextending promotional spend.

Q: What risks should stakeholders monitor? A: Key risks include macroeconomic downturns that reduce premium spending, pricing elasticity that could suppress volumes in vulnerable markets, execution risk in localising premium products, and the need to convert increased investment into measurable market share gains.

Q: How should retailers react to Unilever’s premium focus? A: Retailers should curate assortments to enable premium discovery (promotional space, sampling, digital tie‑ins), work closely on planograms to reflect rationalised portfolios, and align loyalty programmes to capture repeat purchase behavior for premium and Wellbeing products.

Q: What metrics will indicate whether Unilever’s strategy is succeeding? A: Watch premium product repeat purchase rates, digital commerce margin and retention, market share movement in targeted categories, gross margin progression once investment phases end, and regional sales stability (especially in the US and India).

Q: Will portfolio rationalisation hurt Unilever long term? A: Rationalisation can deliver benefits—lower complexity and higher ROI per SKU—if managed well. Long‑term risk arises if pruning removes entry points for consumers without adequate replacement SKUs, or if retailer relationships deteriorate due to reduced assortment. Proper transition planning mitigates these risks.

Q: What should investors expect for 2026? A: Management expressed confidence for the year ahead. Investors should expect continued emphasis on premiumisation and digital commerce, with careful attention to the pace of margin recovery once investments scale. Short‑term volatility may persist, but the strategic pathway is clear: reinforce Power Brands, expand Wellbeing and capture premium growth where feasible.